Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients [Yahoo! Finance]
Labcorp Holdings Inc. (LH)
Last labcorp holdings inc. earnings: 4/29 06:53 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=84636&p=irol-irhome
Company Research
Source: Yahoo! Finance
BOSTON and BURLINGTON, N.C. Nov. 26, 2024 /PRNewswire/ -- Outcomes4Me Inc ., the developer of the first and only end-to-end, actionable cancer platform, announced today it has been selected to present the results of a biomarker awareness study, conducted with Labcorp, a global leader of innovative and comprehensive laboratory services, at the prestigious 2024 San Antonio Breast Cancer Symposium (SABCS) on December 13, 2024 . SABCS is the preeminent conference for sharing cutting-edge breast cancer research with healthcare professionals, researchers, and patient advocates worldwide. "Following the results of the DESTINY-BREAST04 trial at the American Society of Clinical Oncology meeting in 2022, HER2-low emerged as an important biomarker within metastatic breast cancer (mBC)," said Maya R. Said, Sc. D., Founder and CEO of Outcomes4Me. "We knew that many patients living with mBC would benefit from understanding their HER2-low status. We recognize the need to translate the latest clin
Show less
Read more
Impact Snapshot
Event Time:
LH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LH alerts
High impacting Labcorp Holdings Inc. news events
Weekly update
A roundup of the hottest topics
LH
News
- Labcorp Launches H5 Bird Flu Test Amid US Outbreak: Stock to Gain? [Yahoo! Finance]Yahoo! Finance
- Laboratory Co. of America Holdings (NYSE: LH) had its price target raised by analysts at Morgan Stanley from $260.00 to $270.00. They now have an "overweight" rating on the stock.MarketBeat
- LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal [Yahoo! Finance]Yahoo! Finance
- Lip Injection Market to hit USD 5.95 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
- Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians [Yahoo! Finance]Yahoo! Finance
LH
Earnings
- 10/24/24 - Beat
LH
Sec Filings
- 12/4/24 - Form 4
- 12/4/24 - Form 4
- 12/4/24 - Form 4
- LH's page on the SEC website